1989
DOI: 10.1210/jcem-69-4-697
|View full text |Cite
|
Sign up to set email alerts
|

Endocrine Hypertension*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1992
1992
2012
2012

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 31 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…On the other hand, CRH stimulates the release of other POMC-derived peptides from the pituitary including a-melanocyte-stimulating hormone (MSH) (Livesey et al, 1988;Verburg-van Kemenade et al, 1987) which has been shown to stimulate aldosterone production in the zona glomerulosa (Zhu et al, 1991). In clinical studies, patients suffering from adrenal hypertension due to Conn's syndrome with mixed adenomas that secrete both aldosterone and cortisol have been described (Melby, 1989). If cells like the ones observed after stimulation of the animals in the transitional zone between zona glomerulosa and zona fasciculata also exist in human adrenals, they may form the basis of these clinicopathological observations.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, CRH stimulates the release of other POMC-derived peptides from the pituitary including a-melanocyte-stimulating hormone (MSH) (Livesey et al, 1988;Verburg-van Kemenade et al, 1987) which has been shown to stimulate aldosterone production in the zona glomerulosa (Zhu et al, 1991). In clinical studies, patients suffering from adrenal hypertension due to Conn's syndrome with mixed adenomas that secrete both aldosterone and cortisol have been described (Melby, 1989). If cells like the ones observed after stimulation of the animals in the transitional zone between zona glomerulosa and zona fasciculata also exist in human adrenals, they may form the basis of these clinicopathological observations.…”
Section: Discussionmentioning
confidence: 99%
“…It cannot be assumed that pressor sensitivity to noradrenaline will be the same in Cushing's syndrome of varying aetiologies. Although features of mineralocorticoid hypertension are frequent in adrenal carcinoma ( Melby, 1989), they are absent in most patients with pituitary dependent disease, that group having normal serum potassium, total exchangeable sodium, renin and aldosterone ( Dalakos et al ., 1978 ; Ganguly et al ., 1983 ; Ritchie et al ., 1990 ), although some abnormalities in deoxycorticosterone (DOC) and 19‐nor‐DOC has been reported ( Melby, 1989). In addition a recent study suggested that reduced 11 beta‐hydroxysteroid dehydrogenase activity may play a role in the hypertension of Cushing's syndrome of different aetiologies (Stewart et al ., 1985), but the extent of the abnormality of cortisol metabolism was variable, being most marked in patients with ectopic ACTH syndrome.…”
Section: Discussionmentioning
confidence: 99%